http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0607241-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2006-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dc580579159a82b5c52f46c440549c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_419f28913db0c4b653ec69a5c26e84df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f420c5a22a29e9093f14e38f2f83a76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c524fc5ee0715def6de134ac4f9d308
publicationDate 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0607241-A2
titleOfInvention phenyl methanone derivatives and their use as glycine transporter inhibitors 1
abstract PHENYL METHANONE DERIVATIVES AND THE USE OF THE SAME AS GLYCIN CARRIER INHIBITORS 1. The present invention relates to compounds of formula IA or IB. The compounds may be used for the treatment of glycine transporter inhibitor-related diseases.
priorityDate 2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453

Total number of triples: 34.